Emergent BioSolutions (EBS) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2026)
Emergent BioSolutions (EBS) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 72.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 5.97% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.22% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -94.22% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2,287.50% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -15.38% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -407.69% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -300.00% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 76.47% |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn | -94.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.12% |
| Dec 31, 2025 | -68.42% |
| Sep 30, 2025 | -55.83% |
| Jun 30, 2025 | 95.91% |
| Mar 31, 2025 | 600.00% |
| Dec 31, 2024 | 35.23% |
| Sep 30, 2024 | 140.55% |
| Jun 30, 2024 | -4.26% |
| Mar 31, 2024 | 104.58% |
| Dec 31, 2023 | 34.33% |
| Sep 30, 2023 | -190.29% |
| Jun 30, 2023 | -386.79% |
| Mar 31, 2023 | -4,022.22% |
| Dec 31, 2022 | -137.22% |
| Sep 30, 2022 | -133.33% |
| Jun 30, 2022 | -10,500.00% |
| Mar 31, 2022 | -107.32% |
| Dec 31, 2021 | 4.65% |
| Sep 30, 2021 | -202.74% |
| Jun 30, 2021 | -100.58% |